A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus
NCT00873561
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
188
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG:
NBI-6024
Sponsor
Neurocrine Biosciences